Filing Flows › Mesa Laboratories (MLAB) › Q4 FY26 › vs Q4 FY25
Mesa Laboratories (MLAB) Q4 FY26 vs Q4 FY25 (year over year)
Mesa Laboratories's revenue rose $1.6M (+3%) from $62.1M in Q4 FY25 to $63.7M in Q4 FY26.
Mesa Laboratories, Q4 FY26: revenue $63.7M (+3% year over year), operating margin 4.3%, net loss $4.1M, operating cash flow $14.0M. The chart draws each line against Q4 FY25, the increases inside each band.
Margins
| Q4 FY26 | Q4 FY25 | Change | |
|---|---|---|---|
| Free cash flow margin | 21.3% | 19.2% | +2.1 pts |
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $63.7M | $62.1M | $1.6M | +3% |
| Net loss | $4.1M | $7.1M | −$3.0M | -42% |
| Costs & expenses | $67.9M | $69.2M | −$1.4M | -2% |
| Operating costs | $61.0M | $60.7M | $310K | +0.5% |
| Interest & other, net | $4.3M | $1.0M | $3.3M | +331% |
| Income tax | $2.5M | $7.6M | −$5.0M | -66% |
| Cost of revenue | $21.5M | $23.7M | −$2.2M | -9% |
| Research & development | $5.2M | $5.1M | $151K | +3% |
| Sales & marketing | $10.1M | $11.3M | −$1.2M | -11% |
| General & admin | $24.1M | $20.6M | $3.6M | +17% |
| Operating cash sources | $18.1M | $19.8M | −$1.7M | -8% |
| Depreciation & amortization | $5.8M | $7.5M | −$1.7M | -23% |
| Share-based compensation | $6.8M | $3.1M | $3.7M | +116% |
| Working capital & other | $5.6M | $9.1M | −$3.6M | -39% |
| Net loss absorbed | $4.1M | $7.1M | −$3.0M | -42% |
| Operating cash flow | $14.0M | $12.7M | $1.3M | +10% |
| Free cash flow (OCF − capex) | $13.5M | $11.9M | $1.6M | +14% |
| Capital expenditures | $417K | $757K | −$340K | -45% |
Questions
How much did Mesa Laboratories's revenue grow year over year in Q4 FY26?
Mesa Laboratories's revenue rose $1.6M (+3%) from $62.1M in Q4 FY25 to $63.7M in Q4 FY26.